___
Bio-Rad Laboratories, Inc. (NYSE:BIO) a multinational manufacturer and distributor of life science research and clinical diagnostic products, will report financial results for the fourth quarter and full year 2010 on Thursday, February 24, 2011, after the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day. Interested parties may access the call by dialing 866-202-0886 (in the U.S.) or 617-213-8841 (international), access number 25027707. A live webcast of the conference call may be accessed in the “Investor Relations” section of www.bio-rad.com. A replay of the call will be available at 888-286-8010 (in the U.S.) or 617-801-6888 (international), access number 51107717, for seven days following the call. The webcast of the call will be archived on the Bio-Rad site for on-demand replay for up to a year and may be accessed in the “Investor Relations” section of the website.
Bio-Rad Laboratories, Inc., together with its subsidiaries, manufactures and supplies the life science research, healthcare, analytical chemistry, and other markets worldwide with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze, and purify their components.
*****
Power3 Medical Products, Inc. (PWRM.OB)
Parkinson’s disease typically has effects on people around 50. The early signs of PD tend to be subtle and also occur gradually. When it comes to some people the condition moves along more rapidly than in others. The fact that the condition moves along to shaking or tremors, creates a dibilitating effect on nearly all PD individuals which restrict every day tasks. Other signs and symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests which can support in diagnosing sporadic PD. For that reason the medical diagnosis is determined by track record and a neurological examination. The illness can be tough to diagnose precisely. Physicians may sometimes demand brain scans or laboratory tests in order to exclude other diseases.
Power3 Medical Products, Inc., a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, recently announced PWRM management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.
In addition, PWRM is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by PWRM several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for PWRM’s depressed stock price and have distracted the company from its mission, PWRM plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, PWRM will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. PWRM intends to appeal this decision.
To learn more about PWRM visit: http://www.Power3Medical.com
*****
SunTrust Banks, Inc. (NYSE:STI) has won 18 Greenwich Excellence Awards for distinguished performance in serving the financial needs of business clients in 2010, doubling the number of Greenwich Awards received in 2009. The number of SunTrust’s 2010 Greenwich Excellence awards is among the highest received by any financial institution across the nation. With 12 awards in the Small Business Banking category and six in the Middle Market Banking category (complete list below), SunTrust is among an elite group to be recognized. Less than five percent of financial institutions were selected for awards out of more than 750 eligible providers, and with 18 total awards, SunTrust is one of the top recipients nationwide.
SunTrust Banks, Inc. operates as the holding company for SunTrust Bank, which provides various financial services to consumer and corporate customers in the United States.
*****
American Video Teleconferencing Corp. (AVOT.PK)
China has been one of the main supplier to the US of the Earth’s rare mineral supplies, with these rare minerals American manufacturers are able to make high-tech products such as cell phones, wind turbines, and guided missiles, but all that might come to a screeching halt now that China has stopped supplying the material, the New York Times has reported.
In the wake of China’s decision America now must look for other sources, that will be more reliable for our future needs, and AVOT may just be the new source, here’s why.
AVOT believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings. AVOT is currently looking for these Rare Earths Minerals in Canada, the US’s Northern neighbor.
American Video Teleconferencing Corp. recently reported that it is presently in final discussions to enter into a formal agreement to acquire an exclusive option on a molybdenum property in the Otter lake area in the province of Quebec, Canada. The property has been dormant since the 1960’s when Hupon Mining and Exploration carried out surface work, stripping, trenching and a minor drill program of 445 feet contained in 11 drill holes. Some of the sample results from the trenching in 1962 showed 0.94% to 25% molybdenum averaging 5-10%. These values were obtained from assessment files in the Department of Mines in Quebec City.
This property is only one of several advanced stage properties AVOT has under consideration in the province of Quebec.
*****
Celanese Corp. (NYSE:CE) a global technology and specialty materials company, announced that its wholly owned subsidiary, Celanese Far East Limited, has signed letters of intent to construct and operate industrial ethanol production facilities in Nanjing, China, at the Nanjing Chemical Industrial Park and in Zhuhai, China, at the Gaolan Port Economic Zone. Pending project approvals, Celanese could begin industrial ethanol production within the next 30 months with an initial nameplate capacity of 400,000 tons per year per plant with an initial investment of approximately US$300 million per plant. The company is pursuing approval at two locations to ensure its ability to effectively grow with future demand.
Celanese Corporation engages in producing and selling industrial chemicals, acetyl products, and engineered polymers in North America, Europe, and Asia.
___
********************************************************************
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB) has received from the company 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (AVOT.PK) for 12 months IR Services and 1,000,000 shares of (144) restricted common stock for its IT services. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).
